AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 191 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $4,304,000 | +77.9% | 316,933 | -0.7% | 1.04% | +41.0% |
Q1 2020 | $2,419,000 | +22.4% | 319,073 | +2.1% | 0.73% | +57.5% |
Q4 2019 | $1,976,000 | +61.3% | 312,609 | 0.0% | 0.47% | +54.3% |
Q3 2019 | $1,225,000 | -19.0% | 312,609 | 0.0% | 0.30% | -16.8% |
Q2 2019 | $1,513,000 | -40.9% | 312,609 | 0.0% | 0.36% | -41.6% |
Q1 2019 | $2,560,000 | +38.5% | 312,609 | -6.5% | 0.62% | +21.2% |
Q4 2018 | $1,849,000 | -30.5% | 334,328 | +11.0% | 0.51% | -21.4% |
Q3 2018 | $2,659,000 | -22.0% | 301,182 | -11.8% | 0.65% | -14.6% |
Q2 2018 | $3,408,000 | +13.8% | 341,489 | +8.6% | 0.76% | +12.2% |
Q1 2018 | $2,996,000 | – | 314,401 | – | 0.68% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |